Sunitinib Malate



Indications and Reactions:

Role Indications Reactions
Primary
Renal Cell Carcinoma 23.5%
Hypertension 10.6%
Metastatic Renal Cell Carcinoma 10.6%
Prostate Cancer 8.3%
Gastrointestinal Stromal Tumour 6.8%
Breast Cancer 5.0%
Prophylaxis 4.6%
Pain 4.3%
Colorectal Cancer 3.4%
Nausea 2.8%
Hepatic Neoplasm Malignant 2.7%
Constipation 2.6%
Diabetes Mellitus 2.4%
Non-small Cell Lung Cancer 2.3%
Renal Cancer 2.3%
Renal Cancer Metastatic 1.8%
Diarrhoea 1.7%
Insomnia 1.6%
Hypothyroidism 1.5%
Dyspepsia 1.2%
Death 9.9%
Thrombocytopenia 8.8%
Platelet Count Decreased 8.7%
White Blood Cell Count Decreased 8.2%
Vomiting 7.7%
Pyrexia 6.3%
Pleural Effusion 6.3%
Pneumonia 5.7%
Renal Failure 5.2%
Renal Cell Carcinoma 4.9%
Sepsis 4.1%
Renal Failure Acute 3.6%
Osteonecrosis Of Jaw 3.4%
Myocardial Infarction 3.3%
Syncope 2.7%
General Physical Health Deterioration 2.6%
Pulmonary Embolism 2.3%
Dehydration 2.1%
Ascites 2.0%
Interstitial Lung Disease 1.9%
Secondary
Renal Cell Carcinoma 19.7%
Metastatic Renal Cell Carcinoma 9.3%
Product Used For Unknown Indication 8.7%
Hypertension 8.2%
Breast Cancer 7.0%
Prophylaxis 6.9%
Gastrointestinal Stromal Tumour 6.9%
Pain 5.8%
Prostate Cancer 5.5%
Colorectal Cancer 3.7%
Constipation 3.2%
Drug Use For Unknown Indication 3.1%
Non-small Cell Lung Cancer 1.8%
Gastrooesophageal Reflux Disease 1.7%
Renal Cancer 1.5%
Transitional Cell Carcinoma 1.5%
Hypothyroidism 1.4%
Metastatic Gastric Cancer 1.4%
Nausea 1.3%
Hepatic Cirrhosis 1.3%
Vomiting 12.9%
Death 11.6%
Renal Cell Carcinoma 11.4%
Pyrexia 6.1%
Sinusitis 5.5%
Malaise 5.3%
Pleural Effusion 5.3%
Osteonecrosis Of Jaw 4.8%
Thrombocytopenia 4.5%
Pulmonary Embolism 3.8%
Neoplasm Malignant 3.7%
Diarrhoea 3.6%
Pneumonia 3.6%
Aortic Dissection 2.9%
Pneumonitis 2.6%
Renal Failure Acute 2.6%
White Blood Cell Count Decreased 2.6%
Hypertension 2.5%
Platelet Count Decreased 2.5%
Pneumonia Bacterial 2.2%
Concomitant
Metastatic Renal Cell Carcinoma 62.5%
Renal Cell Carcinoma 10.4%
Prophylaxis 7.0%
Metastases To Bone 2.3%
Drug Use For Unknown Indication 2.0%
Hypertension 1.7%
Prostate Cancer 1.6%
Metastases To Thorax 1.4%
Insomnia 1.3%
Renal Cancer 1.2%
Asthenia 1.0%
Diarrhoea 1.0%
Appetite Disorder 1.0%
Oral Candidiasis 1.0%
Anorexia 0.9%
Fatigue 0.9%
Pain 0.9%
Gastrointestinal Stromal Tumour 0.7%
Headache 0.6%
Pyrexia 0.6%
Neoplasm Malignant 12.7%
Stomatitis 10.7%
Osteonecrosis Of Jaw 9.8%
Malignant Neoplasm Progression 7.4%
Osteonecrosis 5.7%
Pneumonia Aspiration 5.7%
White Blood Cell Count Decreased 4.9%
C-reactive Protein Increased 4.1%
Neoplasm Progression 3.7%
Platelet Count Decreased 3.7%
Pyrexia 3.7%
Anaemia 3.3%
Haemoglobin Decreased 3.3%
Hyperglycaemia 3.3%
Pneumonia 3.3%
Vomiting 3.3%
Blood Alkaline Phosphatase Increased 2.9%
Blood Lactate Dehydrogenase Increased 2.9%
Death 2.9%
Sepsis 2.9%
Interacting
Prostate Cancer 11.4%
Product Used For Unknown Indication 10.1%
Breast Cancer 8.9%
Insomnia 7.6%
Depression 6.3%
Metastatic Renal Cell Carcinoma 6.3%
Asthma 5.1%
Headache 5.1%
Hypothyroidism 5.1%
Pneumonia 5.1%
Thrombosis Prophylaxis 5.1%
Gastrointestinal Stromal Tumour 3.8%
Non-small Cell Lung Cancer 3.8%
Renal Cancer 3.8%
Atrial Fibrillation 2.5%
Hypercholesterolaemia 2.5%
Mycosis Fungoides 2.5%
Renal Cell Carcinoma 2.5%
Anxiety 1.3%
Attention Deficit/hyperactivity Disorder 1.3%
Renal Failure Acute 18.2%
Ventricular Dysfunction 13.6%
Gingival Bleeding 9.1%
Neutropenia 9.1%
Renal Failure 9.1%
Drug Interaction 4.5%
Epilepsy 4.5%
Hepatic Failure 4.5%
Mental Status Changes 4.5%
Metabolic Acidosis 4.5%
Osteonecrosis Of Jaw 4.5%
Somnolence 4.5%
Thrombocytopenia 4.5%
Vomiting 4.5%